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Seasonality, annual trends, and characteristics of dengue among
ill returned travelers, 1997-2006
Abstract
We examined seasonality and annual trends for dengue cases among 522 returned travelers reported to
the international GeoSentinel Surveillance Network. Dengue cases showed region-specific peaks for
Southeast Asia (June, September), South Central Asia (October), South America (March), and the
Caribbean (August, October). Travel-related dengue exhibited annual oscillations with several
epidemics occurring during the study period. In Southeast Asia, annual proportionate morbidity
increased from 50 dengue cases per 1,000 ill returned travelers in nonepidemic years to an average of
159 cases per 1,000 travelers during epidemic years. Dengue can thus be added to the list of diseases for
which pretravel advice should include information on relative risk according to season. Also, dengue
cases detected at atypical times in sentinel travelers may inform the international community of the
onset of epidemic activity in specific areas.
We examined seasonality and annual trends for den-
gue cases among 522 returned travelers reported to the 
international GeoSentinel Surveillance Network. Dengue 
cases showed region-specifi c peaks for Southeast Asia 
(June, September), South Central Asia (October), South 
America (March), and the Caribbean (August, October). 
Travel-related dengue exhibited annual oscillations with 
several epidemics occurring during the study period. In 
Southeast Asia, annual proportionate morbidity increased 
from 50 dengue cases per 1,000 ill returned travelers in 
nonepidemic years to an average of 159 cases per 1,000 
travelers during epidemic years. Dengue can thus be added 
to the list of diseases for which pretravel advice should in-
clude information on relative risk according to season. Also, 
dengue cases detected at atypical times in sentinel travel-
ers may inform the international community of the onset of 
epidemic activity in specifi c areas.   
An estimated 100 million cases of dengue fever (DF) and 250,000 cases of dengue hemorrhagic fever 
(DHF) occur annually (1). The past 20 years have seen a 
dramatic geographic expansion of epidemic DF and DHF 
from Southeast Asia to the South Pacifi c Islands, the Carib-
bean, and the Americans. An increasing number of reports 
of DF and associated illness among travelers to dengue 
virus–infected areas parallel the changing epidemiology 
of dengue in local populations (2–8). As part of a com-
prehensive analysis of the spectrum of disease in travel-
ers, the GeoSentinel Surveillance Network, a multifaceted 
international practice network, has noted that in terms of 
cumulative case numbers over the past decade, dengue has 
emerged as a more frequent diagnosis than malaria in ill 
travelers who have returned from all tropical regions out-
side of Africa (9,10).
Dengue accounts for up to 2% of all illness in returned 
travelers who visit GeoSentinel clinics (9). Dengue is also 
a major cause of hospitalization in febrile returned travelers 
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(7,11). Prospective seroconversion studies have estimated 
the attack rate of DF in travelers to the tropics to be 2.9% in 
Dutch travelers who spent 1 month in Asia (12); the sero-
conversion rate was 6.7% among Israelis who traveled for 
an average of 5 months (13).
We report year-to-year variability, patient characteris-
tics, travel exposures, and region/country specifi c proportion-
ate illness rates due to dengue in 522 returned travelers. Our 
sample, collected over a decade, was also of suffi cient size 
to examine the seasonality of dengue in travelers by region. 
Finally, the use of travelers as sentinels can help provide 
timely information to the international community about the 
onset of dengue outbreaks in disease-endemic areas.
Methods
GeoSentinel Surveillance Network
GeoSentinel sites are specialized travel/tropical medi-
cine clinics on 6 continents staffed by clinicians who are 
recruited on the basis of demonstrated training, experi-
ence, and publication in travel and tropical medicine lit-
erature. They contribute clinician-based information on all 
ill travelers seen, including travel history (additional detail 
is available from www.geosentinel.org) (9,14). The sites 
that account for most patient intake are within academic 
centers; several smaller volume sites (almost all with cur-
rent academic affi liation) are in freestanding locations. 
The intake at sites refl ects a mixed population of tertiary 
care and self-referred patients. Some sites are restricted to 
outpatients, and no one site limits its entire practice to ill 
travelers. To be eligible for inclusion in the GeoSentinel 
database, patients must have crossed an international bor-
der and be seeking medical advice at a GeoSentinel clinic 
for a presumed travel-related illness. Anonymous surveil-
lance data that cannot be linked to an individual patient are 
entered into an SQL database at a central data center. Final 
diagnoses reported by physicians are used to assign diag-
nostic codes from a standardized list of >500 etiologic or 
syndromic diagnoses (9).
Inclusion/Exclusion Criteria
All returning travelers who reported to a GeoSentinel 
site in their current country of residence from October 1, 
1997, to March 1, 2006, were eligible for analysis. Many 
GeoSentinel sites also enter data separately on immigrants 
with no other travel but the initial immigration trip. None 
of the patients in this immigrant dataset had a diagnosis of 
dengue acquired in the country of origin. The current study 
is restricted to traditional travelers, which also includes 
immigrants who subsequently traveled from their current 
country of residence.
Patients were excluded if no confi rmed or probable di-
agnosis was reported. A case of travel-associated dengue 
was defi ned per current annual surveillance reports (15–17), 
which consider both probable and confi rmed cases of den-
gue (18). A case of travel-associated dengue was defi ned as 
laboratory-diagnosed dengue in a resident of a non–dengue-
endemic area who has traveled to a dengue-endemic area in 
the 14 days before symptom onset. Laboratory-diagnosed 
dengue was determined by isolation of dengue virus, vi-
rus antigen, or viral RNA, or a serum sample positive for 
either immunoglobulin (Ig) M or a very high titer of IgG 
by ELISA. All sites use best available reference diagnos-
tics for their respective countries, which may include well-
characterized commercial kits. GeoSentinel criteria for the 
diagnosis of malaria have been reported (19).
Statistical Analysis
Analysis of dengue reports over time was based on pro-
portionate morbidity (the number of patients with dengue 
fever as a proportion of the number of ill returned travelers 
visiting a GeoSentinel clinic in that month). Analysis of an-
nual and monthly cycles was based on monthly proportion-
ate morbidity aggregated over all years of data included in 
the analysis. Patients who were reported as having dengue 
were compared with all other ill returned travelers in Geo-
Sentinel. A subanalysis, comparing dengue patients with 
malaria patients, was also performed. We used χ2 or Fisher 
exact test as appropriate with a 2-sided signifi cance level of 
0.05. Data analysis was performed by using SAS statistical 
package version 9 (SAS Institute, Cary, NC, USA).
Results
Among ill returned travelers seen at GeoSentinel sites 
from October 1997 through February 2006, 24,920 met the 
criteria for analysis. Of these, 522 (2.1%) had a diagnosis 
of travel-related dengue fever, including 12 patients with 
dengue hemorrhagic fever or dengue shock syndrome. Of 
the 522 cases of dengue reported in this study, 68% were 
seen after travel to Asia, 15% after travel to Latin America, 
9% after travel to the Caribbean, 5% after travel to Africa, 
and 2% after travel to Oceania (Table 1). The countries 
with the largest number of cases reported among returned 
travelers were Thailand (154), India (66), Indonesia (38), 
and Brazil (22).
Annual Trends in Travel-related Dengue 
and Changes during Regional Epidemics
A comparison of the annual trends in illness from den-
gue as a proportion of all diagnoses in ill returned travelers 
showed sustained increases in dengue proportionate mor-
bidity, represented by peaks that are both high and broad in 
1998 and 2002. There was also a narrow peak in October 
2003 and an increase in late 2005 (Figure 1). When dengue 
reports were segregated by region, the increases in 1998 
and 2002 were found entirely in travelers to Southeast Asia; 
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for 2003, in travelers to South Central Asia; and for 2005, 
in travelers to South Central Asia and Indonesia. These in-
creases correspond to known epidemic years within local 
populations for those regions (20,21).
Since travel-related dengue was found to originate 
most commonly in Southeast Asia, more detailed analysis 
could be performed for that region. Dengue proportionate 
morbidity among ill returned persons who had traveled to 
Southeast Asia, which was a mean of 71 per 1,000 dur-
ing the cumulative 1997–2006 period (Figure 2, panel A), 
was 159 cases per 1,000 ill returned travelers during 1998 
and 2002 taken together (Figure 2, panel A); proportionate 
morbidity reached a peak of >200 cases per 1,000 ill re-
turned travelers during June and July. Of the 264 Southeast 
Asian cases, 154 that were acquired in Thailand could be 
plotted separately (Figure 2, panel B). Dengue proportion-
ate morbidity among ill persons who had traveled to Thai-
land, which was an average of 101 cases per 1,000 during 
the cumulative 1997–2006 period (Figure 2, panel B), was 
257 cases per 1,000 ill returned travelers during 1998 and 
2002 taken together (Figure 2, panel B) and was >500 cases 
per 1,000 ill returned travelers during the peak month of 
June (i.e., more than half of all ill travelers returning from 
Thailand had dengue).
Seasonality of Travel-associated Dengue
Figure 3 shows month-by-month dengue cases as a 
proportion of all illness in ill returned travelers during the 
study period for each region separately. For Southeast Asia, 
dengue cases generally peaked in June and September in 
typical nonepidemic years. However, an examination of 
the outbreak years of 1998 and 2002 showed that seasonal 
patterns changed markedly when compared with nonout-
break years; excess cases were seen for every month except 
January, and a high and sustained peak occurred from April 
through August (Figure 2, panel A). In Thailand, during 
the outbreak years, proportionate morbidity exceeded the 
mean 1997–2006 proportionate morbidity (Figure 2, panel 
B) for all months except January. Notably, the major peak 
of illness began in April, a time of minimal dengue activity 
in nonoutbreak years. The major epidemic peak in sentinel 
travelers preceded the epidemic pattern in the local popula-
tion during 1998 and 2002, as refl ected in Thai reports to 
the World Health Organization (20).
An examination of seasonality in travelers for other 
regions (Figure 3) showed that dengue cases were higher 
from September through December in South Central Asia 
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Table 1. Dengue and malaria diagnoses as a proportion of all morbidity in ill returned travelers according to region or country of 
acquisition
Region* or country of exposure
No. ill returned 
travelers with 
dengue
No. ill returned 
travelers with 
malaria









Southeast Asia 264 103 3,694 71 28
 Thailand 154 9 1,523 101 5
 Indonesia 38 53 652 58 81
South Central Asia 90 70 3,303 27 21
 India 66 57 2,119 31 27
Caribbean 47 14 1,470 32 9
South America 40 49 2,427 16 20
 Brazil 22 12 685 32 18
Central America 37 27 1,867 20 14
Africa 25 1,216 7,231 3 168
 Sub-Saharan Africa 23 1,201 6,201 4 194
Oceania 11 91 303 36 300
Other‡ or multiple regions of 
exposure
7 23 4,443 2 5
Country missing 1 12 182 5 66
Total 522 1,605 24,920 21 64
*Regions defined per (9). 
†Proportionate morbidity expressed per 1,000 ill returned travelers seen at GeoSentinel clinics. 
‡No cases were acquired in Canada, United States, Western Europe, Japan, or Australia. 
Figure 1. Dengue fever in returned travelers as a proportion of 
monthly morbidity in all ill returned travelers to all regions of the 
world. Cumulative proportionate morbidity of 21 per 1,000 ill 
returned travelers (522 dengue reports among 24,920 ill travelers 
from October 1997 through February 2006) is shown by the 
horizontal line. *Proportionate morbidity is expressed as number of 
dengue cases per 1,000 ill returned travelers.
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(especially in India, which accounted for most of our cas-
es in South Central Asia; Table 1). A sharp and consis-
tent major peak can be seen each October throughout the 
study period. This closely tracks the monthly pattern in the 
Indian population during 2003–2006, years for which ro-
bust Indian national data are available (21). The number of 
dengue cases in travelers was higher from August through 
December in the Caribbean; it was highest in March in 
South America, especially in Brazil, which accounted for 
most of our cases in South America (Table 1). This peak is 
also consistently seen in the Brazilian population (22) each 
year. No evidence of a strong seasonal pattern was found in 
travelers to Central America and Africa, although the num-
bers of travelers to these regions in our sample were small.
Characteristics of Travelers with Dengue
The characteristics of travelers with dengue are com-
pared in Table 2 with the characteristics of those with all 
other diagnoses. The mean age of dengue patients was 
33.8 years; the male:female ratio was 1.17:1. Of the pa-
tients studied, 69.3% were traveling only for tourism, and 
the median trip duration was <28 days. Most of the den-
gue case-patients (61%) had a pretravel encounter, a sig-
nifi cantly higher percentage than for ill returned travelers 
without dengue (53%; p<0.005). Dengue is overwhelm-
ingly a disease of young adults 18–44 years of age. As ex-
pected, due to the short incubation period, >75% of dengue 
case-patients sought treatment within 2 weeks after return. 
In addition, signifi cantly more dengue patients were hospi-
talized (24% vs. 6%; p<0.001), a level similar to the 25% 
rate reported in a study of European travelers (4).
Comparison of Dengue and Malaria 
Patient Characteristics 
During the study period, 1,605 (6.4%) ill returned trav-
elers reported to GeoSentinel had been given a diagnosis 
of malaria. A comparison of the characteristics of travelers 
with dengue and those with malaria shows some impor-
tant differences. Unlike dengue, which affects both sexes 
almost equally, malaria is more common in male travelers 
(11,23). Patients with malaria were less likely to have a re-
corded pretravel encounter. Duration of travel (median 34 
days) was signifi cantly longer than for travelers returning 
with dengue (median 28 days; p<0.05), although the dif-
ference was not large. Malaria was much more common in 
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Figure 2. Changes in dengue morbidity during regional epidemics. 
Heavy red and blue lines show dengue in returned travelers as 
a proportion of monthly morbidity in all ill returned travelers to 
Southeast Asia (A) and Thailand (B) during the epidemic years 
of 1998 and 2002 (red lines) and during all other nonepidemic 
years (blue lines). Black horizontal dashed lines represent mean 
proportionate morbidity over all months for that area during the 
cumulative 1997–2006 period in travelers; red horizontal dashed 
lines represent mean proportionate morbidity over all months 
during the 2 outbreak years (1998 and 2002) in travelers. Each 
gray line in panel B tracks month-by-month reports to the World 
Health Organization (WHO) of the total number of dengue cases 
in the endemic Thai population for a single year from 1998–2005. 
*Proportionate morbidity is expressed as number of dengue cases 
per 1,000 ill returned travelers.
Figure 3. Seasonality of dengue in returned travelers by region. 
Dengue in returned travelers is shown as a proportion of monthly 
morbidity in all ill returned travelers to each region. Horizontal 
dashed lines represent the mean proportionate morbidity over all 
months for that region during the cumulative 1997–2006 period in 
travelers. Data for Southeast Asia exclude the outbreak years of 
1998 and 2002. *Proportionate morbidity is expressed as number 
of dengue cases per 1,000 ill returned travelers.
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Dengue Trends and Seasonality in Travelers
fi rst- or second-generation immigrants visiting friends and 
relatives (Table 2).
Overall, the proportion of travelers with dengue in 
the GeoSentinel database (21 cases per 1,000 ill returned 
travelers) was less than the proportion seen with malaria 
(64 cases per 1,000 ill returned travelers; Table 1). This 
fi nding, however, was mostly due to the disproportionate 
numbers of travelers returning ill from Africa where ma-
laria is highly prevalent (168 cases per 1,000 ill returned 
travelers) and where dengue is rare (3 cases per 1,000 ill 
returned travelers). A similar situation applies to Oceania 
where malaria (300 cases per 1,000 ill returned travelers) is 
signifi cantly more frequent than dengue fever (36 cases per 
1,000 ill returned travelers). For other regions, the propor-
tionate morbidity due to dengue was higher than that due 
to malaria, except for South America, where proportionate 
morbidity was approximately equal (20 cases vs. 16 cases 
per 1,000 ill returned travelers). 
Analysis of travel to several countries was possible. 
Dengue proportionate morbidity (101 cases per 1,000 ill 
returned travelers) was dramatically higher than that for 
malaria (5 cases per 1,000 ill returned travelers) in travel-
ers returning from Thailand and exceeded that for malaria 
in travelers returning from Brazil and India.
Discussion
Data collected longitudinally over a decade by the Geo-
Sentinel Surveillance Network have allowed us to examine 
month-by-month illness from a sample of 522 patients with 
dengue (as a proportion of all diagnoses among 24,920 ill 
returned travelers) seen at our 33 surveillance sites. Travel-
related dengue demonstrates defi ned seasonality for some 
regions (Southeast Asia, South Central Asia, the Caribbe-
an, and South America; Figure 3). Although discrete peaks 
are present, the number of cases from the Caribbean and 
South America is relatively small. A June peak of travel-
related dengue was previously reported in a small sample 
of 75 Swedish travelers to Thailand (using imported cases 
from 1998–1999) (3). Several vector-borne diseases, such 
as malaria (24) and Japanese encephalitis (25), are known 
to exhibit seasonality in local populations, but no fi rm data 
exist on whether this pertains to travelers’ risk. Our fi nd-
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Table 2. Demographic characteristics and type of travel for ill returned travelers with dengue, malaria, or any other diagnosis
Characteristic
Ill returned travelers 
with dengue
Ill returned travelers 
with malaria
Ill returned travelers without 
dengue or malaria
Total  ill returned 
travelers
No. cases 522 1,605 22,793 24,920
Age group, %*
 <18 y 1.3 5.6 3.9 3.9
 18–44 y 79.2 68.4 69.1 69.3
 45–55 y 12.4 17.2 14.7 14.7
>56 y 7.1 8.9 12.4 12.0
Female sex, %* 46.1 30.1 49.7 48.3
Pretravel encounter, %*
 Yes 61.3 42.8 53.6 53.1
 No 28.6 43.7 33.6 34.1
 Unknown 10.1 13.5 12.8 12.8
Inpatient, %* 24.8 50.3 6.6 9.8
Duration of travel, d*
 25% travelers 14 d 21 d 14 d 14 d
 50% travelers 28 d 34 d 28 d 28 d
 75% travelers 67 d 95 d 132 d 123 d
Time from travel to symptoms, %*
 <2 week 75.5 53.3 41.8 43.3
>2 week 24.5 46.7 58.2 56.7
Patient classification %*
 Immigrant 7.9 35.1 13.6 14.9
 Temporary visitor 4.2 2.2 1.6 1.7
 Expatriate 8.4 13.7 10.0 10.2
 All other travelers 79.5 48.4 74.5 73.1
Reason for recent travel, %*
 Tourism 69.3 29.1 60.3 58.5
 Business 10.5 16.0 14.0   14.1
 Research/education or 
 Missionary/volunteer
10.2 14.5 12.7 12.8
 Visiting friends or relatives† 9.8 40.1 12.5 14.2
*Significant differences in travelers with dengue vs. malaria (p<0.05). 
†1st or 2nd generation immigrant originally from a low-income country now living in a high-income country, visiting friend and relatives in the country of 
the family’s origin. 
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ings on the seasonality of dengue in travelers benefi ts those 
advising prospective travelers, as well as those formulating 
possible diagnoses in ill returned travelers. Consequently, 
travelers who have had a previous episode of dengue might 
want to avoid peak dengue transmission times at a particu-
lar destination to minimize the risk for developing dengue 
hemmorhaghic fever, which preferentially affects those 
with previous dengue infection (26). For example, the 
February–March peak in Brazil coincides with Carnaval 
(annual festival marking the beginning of Lent). Neverthe-
less, in dengue-endemic regions, risk exists year round, and 
travelers should always be counseled on personal protec-
tion measures against arthropods.
Rainy seasons vary by country and, in many cases, vary 
regionally within countries. Because of these geographic 
variations in the rainy season, we have avoided the tempta-
tion to over generalize about relationships between rainfall 
and dengue incidence (Figure 3). Although GeoSentinel 
would not be likely to receive reports from outbreaks of den-
gue that are restricted to regions of a country not frequented 
by travelers, most substantial outbreaks do eventually spread 
widely (27). In this analysis, proportionate morbidity always 
compares the number of dengue cases with all ill travelers 
seen at GeoSentinel clinics during a particular month. This 
type comparison ensures that the variation in the absolute 
number of travelers to a particular destination at different 
times of year do not distort the results. 
The natural, and to a large extent unexplained, year-to-
year oscillations of dengue cases in local populations have 
been described in some countries (27–29). In travelers, this 
has not been examined over a long period in such a size-
able dataset, while simultaneously comparing regions of the 
world (30). In each of the epidemic years 1998 and 2002 
in Southeast Asia, the usual pattern of seasonality changed 
with an excess of cases throughout the whole year. The out-
break was heralded initially by an excess of cases begin-
ning in February with a dramatic upsurge in April (Figure 
2, panel A), well ahead temporally and in magnitude when 
compared with the usual initial peak month of June. When 
the 1998 pattern in travelers recurred in early 2002, it led 
to the immediate hypothesis that this change of seasonality 
would once again herald an epidemic year. In April 2002, 
GeoSentinel alerted the international community when it 
posted a notice of the increase in travel-related dengue from 
Thailand online (31). Offi cial surveillance data from local 
populations were not immediately available to the interna-
tional community. Data reported later by Thai authorities to 
the World Health Organization confi rmed the observation 
(20). A retrospective report published in 2004 also noted an 
April 2002 surge in dengue cases among German travelers 
to Thailand (32). The increase in dengue cases in returned 
travelers from South Central Asia in 2003 was also evident 
before offi cial surveillance data were available. This in-
crease reinforces the usefulness of sentinel surveillance in 
travelers. For example, travelers’ malaria has identifi ed new 
foci of infection in the Dominican Republic (33) and the Ba-
hamas (34). Because the number of travelers to areas with 
epidemics may be small and some epidemics may occur in 
parts of a country that are not visited by travelers, we are not 
proposing sentinel surveillance as a defi nitive and uniquely 
sensitive tool for detection of all disease outbreaks. A 2001 
outbreak in Thailand apparently did not affect travelers 
(Figure 2, panel B), as it was not associated with a peak in 
reports to GeoSentinel. Nevertheless, the traveling popula-
tion can give timely, very specifi c indicators.
Our data on the high frequency of dengue in travelers 
to Southeast Asia and the Caribbean and its rarity in travel-
ers to Africa are in agreement with previous smaller sam-
ples such as those from a regional European surveillance 
network (TropNetEurop), which examined 238 returning 
travelers with dengue over a 3-year period (1999–2001) 
(4). In comparing proportionate morbidity for dengue be-
tween regions, rates in travelers to the Caribbean approach 
those of some parts of Asia and are thus higher than would 
be expected from overall rates in local populations. These 
rates likely refl ect common travel patterns that may favor 
more risky locales. A new fi nding in our report is the high 
proportionate morbidity in travelers to Oceania, who be-
cause of small absolute numbers of travelers to that region, 
may have been overlooked in earlier studies, which report-
ed only raw numbers of cases.
The limitations of this analysis include those appli-
cable to other published studies that used the GeoSentinel 
database. The fi ndings can only be generalized to travel-
ers seen in tropical or travel medicine clinics after travel. 
In general, data do not represent a sample of all returned 
travelers (e.g., those seen at nonspecialized, primary care 
practices, where milder and self-limited manifestations of 
dengue that might not be recognized as such, would occur 
with greater frequency). The more severely ill patients that 
do seek treatment at specialized clinics such as GeoSenti-
nel sites will likely have higher hospitalization rates than 
the overall population with dengue infection. Patients may 
also seek treatment at GeoSentinel sites and not return for 
follow-up defi nitive diagnostic serology when faced with 
the inconvenience and cost of serologic evaluation of a self-
limited illness, particularly when symptoms have resolved. 
Dengue has a short incubation period; many patients may 
have the disease while still traveling. Nevertheless, the un-
captured cases are not likely to have a different pattern of 
geographic acquisition than those that are included.
In conclusion, current data serve as a reference for 
the seasonality of dengue for several regions of the world. 
Dengue can be added to the list of diseases for which 
pretravel advice can include information on relative risk 
according to season of travel to a particular destination. 
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Further, the season of travel can aid the clinician in as-
sessing the relative likelihood of dengue in an ill returned 
traveler with a nonspecifi c febrile illness. Travelers may 
be sentinels able to rapidly inform the international com-
munity about the onset of epidemics in disease-endemic 
areas. Effective malaria chemoprophylaxis and strategies 
for personal protection against night-feeding malaria vec-
tors are already available. Dengue is a risk for all tourists 
equally without respect to gender, pretravel preparation, 
or duration of travel. Even with good pretravel advice, 
all healthcare providers can do is recommend mosquito 
precautions. The usual preventive measure for an infec-
tious disease is vaccination. Because personal protection 
against the day-feeding dengue vectors is so problematic, 
there is an urgent need for a dengue vaccine.  
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